Lonza to manufacture Alector’s mAb drug candidates for Ph I trial
Lonza will provide manufacturing for Alector’s Phase I drug candidates for neurodegenerative diseases from its Switzerland site, which is expected to be operational by mid-2020.
Archives for May 9, 2019
Pfizer expands rare disease pipeline with $820m buyout
Pfizer will acquire Therachon to gain access to TA-46, the biotech’s lead drug candidate for the treatment of achondroplasia.
Vibalogics makes investment in viral manufacturing to meet increasing demand
Vibalogics increases its single-use bioreactor and purification capacity with a new manufacturing line to meet demand for oncolytic virus and viral vector manufacturing services.
Samsung Biologics to provide CDMO support for ‘bio-venture’ firm GI Innovation
Samsung Biologics is providing contract development services for GI Innovation’s pipeline, with the first among five molecules to initiate development immediately, says company representative.